UNSPSC 51151539: Cevimeline hydrochloride hemihydrate

This classification denotes a cholinergic agonist with the molecular formula 2C10H17NOS.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P81Q6V85NP, chemically known as (+/-)-cis-2-methylspiro(1,3-oxathiolane-5,3'-quinuclidine)hydrochloride, hemihydrate, but more generally known as cevimeline hydrochloride hemihydrate, which bears US NIH Compound Identifier 83927.

European Medicines Agency schedules cevimeline hydrochloride hemihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07461MIG. Most nations, for tariff purposes, schedule cevimeline hydrochloride hemihydrate under HS 29349990. SMILES: C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.O.CL.CL.

UNSPSC 51151539 Cevimeline hydrochloride hemihydrate is a Commodity code nominally identifying a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under it show a significant scope mismatch. Seminole County, Florida's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) solicits procurement of naloxone and drug deactivation systems for community health delivery—a product category unrelated to cevimeline hydrochloride. The Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) seeks vendor information about direct-to-manufacturer prescription programs for state pharmacy benefit administration, a market-intelligence exercise rather than a goods purchase. The code shows minimal relevant recent activity tied to its stated commodity scope.

Geographic activity supporting this code is limited to Florida and Texas based on the two recent opportunities identified. Seminole County represents municipal-level procurement for opioid-overdose response supplies, while the Texas HHS Commission solicitation targets state-level pharmacy program administration. No other states or issuing bodies appear in the recent-opportunities record. The code's nominal pharmaceutical ingredient scope does not align with the actual goods and services state and local governments are currently buying under this classification, suggesting either a data-entry error in the opportunities' UNSPSC tagging or substantial divergence between the code definition and procurement practice on the ground. Firms pursuing genuine cevimeline hydrochloride supply contracts should verify code assignment independently before responding to future solicitations.